(Q43905899)

27 November 2017

title

Impact of diabetes mellitus on the clinical response to cardiac resynchronization therapy in elderly people (English)

1 reference

27 November 2017

Celestino Sardu

1

1 reference

27 November 2017

Raffaele Marfella

series ordinal

2

1 reference

27 November 2017

Gaetano Santulli

series ordinal

3

1 reference

27 November 2017

language of work or name

English

0 references

publication date

6 February 2014

1 reference

Journal of Cardiovascular Translational Research

27 November 2017

published in

1 reference

27 November 2017

volume

7

1 reference

27 November 2017

issue

3

1 reference

27 November 2017

page(s)

362-368

1 reference

Comparative safety and effectiveness of metformin in patients with diabetes mellitus and heart failure: systematic review of observational studies involving 34,000 patients.

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Diabetic cardiovascular disease: getting to the heart of the matter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Diabetes mellitus is associated with adverse prognosis in chronic heart failure of ischaemic and non-ischaemic aetiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Cardiac-resynchronization therapy for the prevention of heart-failure events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

QRS duration, bundle-branch block morphology, and outcomes among older patients with heart failure receiving cardiac resynchronization therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Influence of diabetes on left ventricular systolic and diastolic function and on long-term outcome after cardiac resynchronization therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Long-term outcome in diabetic heart failure patients treated with cardiac resynchronization therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Insulin-treated type 2 diabetes is associated with a decreased survival in heart failure patients after cardiac resynchronization therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Cardiac resynchronization therapy reduces the risk of cardiac events in patients with diabetes enrolled in the multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy (MADIT-CRT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

The ischemic etiology of heart failure in diabetics limits reverse left ventricular remodeling after cardiac resynchronization therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Comparison of effectiveness of cardiac resynchronization therapy in patients <70 versus > or =70 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Clinical features and outcomes of elderly outpatients with heart failure followed up in hospital cardiology units: data from a large nationwide cardiology database (IN-CHF Registry).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

The effect of cardiac resynchronization on morbidity and mortality in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Cardiac resynchronisation therapy response predicts occurrence of atrial fibrillation in non-ischaemic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Regarding the impact of left ventricular size on response to cardiac resynchronization therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Diagnosis of gestational diabetes mellitus: can we avoid the glucose challenge test?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Insulin resistance and risk of incident heart failure: Cardiovascular Health Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Relation of heart-rate recovery to new onset heart failure and atrial fibrillation in patients with diabetes mellitus and preserved ejection fraction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Diabetes mellitus and the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Long-term effects of cardiac resynchronization therapy in octogenarians: a comparative study with a younger population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Gender and survival in patients with heart failure: interactions with diabetes and aetiology. Results from the MAGGIC individual patient meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Hospitalization of patients with heart failure: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Device therapy in patients with heart failure and advanced age: too much too late?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Resynchronization: considering device-based cardiac therapy in older adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

The 6 minute walking test in chronic heart failure: indications, interpretation and limitations from a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Insulin: potential negative consequences of early routine use in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Insulin-sensitizing antihyperglycemic drugs and mortality after acute myocardial infarction: insights from the National Heart Care Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Physical activity ameliorates cardiovascular health in elderly subjects: the functional role of the β adrenergic system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Adrenergic activation, fuel substrate availability, and insulin resistance in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Adrenal signaling in heart failure: something more than a distant ship's smoke on the horizon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Comparison of the Usefulness of Cardiac Resynchronization Therapy in Three Age-Groups (<65, 65-74 and ≥75 Years) (from the InSync/InSync ICD Italian Registry)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Atrial remodelling in echocardiographic super-responders to cardiac resynchronization therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Circulating microRNA changes in heart failure patients treated with cardiac resynchronization therapy: responders vs. non-responders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Clinical response of cardiac resynchronization therapy in the elderly

21 January 2018

1 reference

12 December 2020

Improvement in diastolic function and left ventricular filling pressure induced by cardiac resynchronization therapy

1 reference

12 December 2020

Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study

1 reference

12 December 2020

Rates of complications and mortality in older patients with diabetes mellitus: the diabetes and aging study

1 reference

12 December 2020

Six-year prognosis of diabetic patients with coronary artery disease

1 reference

12 December 2020

Effect of Cardiac Resynchronization on Morbidity and Mortality of Diabetic Patients With Severe Heart Failure

1 reference

12 December 2020

10.1007/S12265-014-9545-9

Identifiers

DOI

1 reference

27 November 2017

1 reference